Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2018-03-30 Transaction in Own Shar…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
第1次庫藏股執行結果
Transaction in Own Shares Classification · 100% confidence The document is a report on the company's share buyback activity, detailing the number of shares repurchased, the price range, the period of buyback, and the purpose (transfer to employees). It includes specific data on shares bought back, total amount spent, average price, and cancellation or transfer of shares. This matches the description of a Transaction in Own Shares (POS) filing, which reports on the company's repurchase or sale of its own shares. The document length is short and focused solely on buyback details, not a broader financial report or announcement. Therefore, the classification is POS with high confidence.
2018-03-30 Chinese
107年3月變更登記
Share Issue/Capital Change Classification · 95% confidence The document is a brief disclosure from a listed company (科妍) providing details about its capital stock, including authorized capital, paid-in capital, capital changes such as capital reduction, and approval dates from regulatory authorities. The content is focused on capital structure changes and regulatory approvals related to capital. The document length is short (813 characters), and it does not contain financial statements or detailed financial analysis. It is not an announcement of a report publication but a direct disclosure of capital information. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2018-03-26 Chinese
公告本公司辦理庫藏股註銷減資變更登記完成
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement (983 characters) from a listed company about the completion of a capital reduction registration due to cancellation of treasury shares. It includes details on capital changes, share counts before and after the reduction, and net asset value per share impact. There is no detailed financial report or comprehensive financial statements, only a regulatory disclosure of a capital change event. This fits the category of Share Issue/Capital Change announcements, which cover share cancellations and capital structure changes. The document is not a full financial report, earnings release, or management discussion, nor is it a voting result or board change. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2018-03-23 Chinese
本公司注射用修飾透明質酸鈉凝膠(醫美微整形用玻尿酸皮下 填補劑)取得中國國家食品藥品監督管理總局(CFDA)核發醫療器械 銷售許可證
Regulatory Filings Classification · 95% confidence The document is a short announcement (761 characters) from a listed company (科妍) reporting that their product has obtained a medical device sales permit from the China Food and Drug Administration (CFDA). It is a factual disclosure about a regulatory approval event, not a financial report or detailed management discussion. There is no indication of financial data, earnings, or meeting materials. The document is an official regulatory announcement about a material event related to product approval. Given the content and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-03-23 Chinese
107年03月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes in shareholding numbers due to capital reduction. It includes specific dates and share counts but does not contain financial statements, management discussion, or detailed report content. The document length is short (1049 characters) and it appears to be a regulatory disclosure of shareholding changes rather than a full report or announcement of a meeting or vote. It fits best as a Major Shareholding Notification (MRQ) because it reports on changes in significant share ownership levels.
2018-03-23 Chinese
106年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to investment in an overseas subsidiary, showing investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (106th year, 4th quarter). The content is tabular and concise, with no comprehensive financial statements or detailed analysis. The document length is only 625 characters, indicating it is a short disclosure rather than a full report. It does not contain a full annual or interim report, nor is it an announcement of a meeting or voting results. It fits best as a Regulatory Filing (RNS) because it is a general regulatory disclosure of investment information that does not fit other specific categories.
2018-03-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.